{"id":360,"date":"2024-09-26T14:14:10","date_gmt":"2024-09-26T14:14:10","guid":{"rendered":"https:\/\/stgmevpro.wpenginepowered.com\/?page_id=360"},"modified":"2025-09-08T12:43:54","modified_gmt":"2025-09-08T12:43:54","slug":"trial-hcp","status":"publish","type":"page","link":"https:\/\/mevproclinicaltrials.com\/en-au\/trial-hcp\/","title":{"rendered":"Trial HCP"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"360\" class=\"elementor elementor-360\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-00e60df header-background e-flex e-con-boxed e-con e-parent\" data-id=\"00e60df\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-37dd70f e-con-full e-flex e-con e-child\" data-id=\"37dd70f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b3cf64b elementor-widget__width-initial elementor-widget-tablet__width-inherit elementor-widget elementor-widget-heading\" data-id=\"b3cf64b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Pfizer MEVPRO Prostate Cancer Clinical Trials<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d8b7b5d hero-heading elementor-widget__width-initial elementor-widget-mobile__width-inherit elementor-widget-tablet__width-inherit elementor-widget elementor-widget-heading\" data-id=\"d8b7b5d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Help advance metastatic prostate cancer treatment research<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-28b8308 e-con-full e-flex e-con e-child\" data-id=\"28b8308\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-272fb55 e-flex e-con-boxed e-con e-parent\" data-id=\"272fb55\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-24e7439 elementor-widget elementor-widget-heading\" data-id=\"24e7439\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Explore Pfizer\u2019s MEVPRO Clinical Trials as potential options for people with prostate cancer<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-357189b4 smalltrial e-flex e-con-boxed e-con e-parent\" data-id=\"357189b4\" data-element_type=\"container\" data-e-type=\"container\" id=\"MEVPRO-1\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-564190de e-con-full e-flex e-con e-child\" data-id=\"564190de\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5211ffb1 elementor-align-start elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"5211ffb1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style>.elementor-element-5211ffb1{display:none !important}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-88646db elementor-align-start elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"88646db\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"23\" height=\"23\" viewbox=\"0 0 23 23\" fill=\"none\"><circle cx=\"11.5\" cy=\"11.5\" r=\"11.5\" fill=\"#097900\"><\/circle><path d=\"M10 7L14.5 11.5L10 16\" stroke=\"white\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Recruiting<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1be04a7e textBreast elementor-widget elementor-widget-text-editor\" data-id=\"1be04a7e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tMEVPRO-1\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-54b00164 elementor-widget elementor-widget-text-editor\" data-id=\"54b00164\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tFor people with abiraterone-resistant metastatic prostate cancer\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-12eb84b2 elementor-align-left elementor-widget elementor-widget-button\" data-id=\"12eb84b2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT06551324?term=NCT06551324&#038;rank=1\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Clinicaltrials.gov<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1a8227d1 elementor-align-left elementor-widget elementor-widget-button\" data-id=\"1a8227d1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/euclinicaltrials.eu\/search-for-clinical-trials\/?lang=en&#038;EUCT=2024-511650-50-00\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Clinicaltrialsregister.eu<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7103bdce e-con-full e-flex e-con e-child\" data-id=\"7103bdce\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-31ed7ff5 elementor-widget elementor-widget-image\" data-id=\"31ed7ff5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"111\" height=\"76\" src=\"https:\/\/mevproclinicaltrials.com\/wp-content\/uploads\/2024\/10\/result-1.svg\" class=\"attachment-full size-full wp-image-442\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6e216dc7 elementor-widget elementor-widget-text-editor\" data-id=\"6e216dc7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tA Phase 3 clinical trial evaluating the investigational drug (mevrometostat) in combination with enzalutamide compared to enzalutamide or docetaxel alone in adults with mCRPC previously treated with abiraterone acetate.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-59482efa learn-more mevpro1Tile elementor-widget elementor-widget-button\" data-id=\"59482efa\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"morebtn5\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-size-sm\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-right\" viewbox=\"0 0 320 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6cfadaa8 learn-more mevpro1Tile elementor-widget elementor-widget-button\" data-id=\"6cfadaa8\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"morebtnopen5\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-size-sm\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-down\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M207.029 381.476L12.686 187.132c-9.373-9.373-9.373-24.569 0-33.941l22.667-22.667c9.357-9.357 24.522-9.375 33.901-.04L224 284.505l154.745-154.021c9.379-9.335 24.544-9.317 33.901.04l22.667 22.667c9.373 9.373 9.373 24.569 0 33.941L240.971 381.476c-9.373 9.372-24.569 9.372-33.942 0z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6c27029f elementor-widget elementor-widget-html\" data-id=\"6c27029f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<script>\n    document.getElementById(\"morebtn5\").onclick = function() {\n      var moreInfoSection = document.getElementById(\"moreinfo5\");\n      moreInfoSection.style.display = (moreInfoSection.style.display === \"none\" || moreInfoSection.style.display === \"\") ? \"block\" : \"none\";\n  \n      \/\/ Toggle visibility of morebtn and morebtnopen\n      document.getElementById(\"morebtn5\").style.display = \"none\";\n      document.getElementById(\"morebtnopen5\").style.display = \"block\";\n    };\n  \n    document.getElementById(\"morebtnopen5\").onclick = function() {\n      var moreInfoSection = document.getElementById(\"moreinfo5\");\n      moreInfoSection.style.display = (moreInfoSection.style.display === \"none\" || moreInfoSection.style.display === \"\") ? \"block\" : \"none\";\n  \n      \/\/ Toggle visibility of morebtn and morebtnopen\n      document.getElementById(\"morebtn5\").style.display = \"block\";\n      document.getElementById(\"morebtnopen5\").style.display = \"none\";\n    };\n  <\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7c176cc9 bigtrial e-flex e-con-boxed e-con e-parent\" data-id=\"7c176cc9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-695a13a0 detailsveritac elementor-widget elementor-widget-template\" data-id=\"695a13a0\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"moreinfo5\" data-widget_type=\"template.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-template\">\n\t\t\t\t\t<div data-elementor-type=\"container\" data-elementor-id=\"447\" class=\"elementor elementor-447\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t<div class=\"elementor-element elementor-element-27aa089b detailsveritav2 e-flex e-con-boxed e-con e-parent\" data-id=\"27aa089b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f7b7d90 elementor-widget elementor-widget-text-editor\" data-id=\"f7b7d90\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tStudy details\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1d10ba88 elementor-widget elementor-widget-text-editor\" data-id=\"1d10ba88\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tMEVPRO-1 is a Phase 3, randomised, open-label clinical trial to evaluate an investigational drug called mevrometostat for men with metastatic castrate-resistant prostate cancer (mCRPC) that has progressed after treatment with abiraterone acetate. MEVPRO-1 will investigate whether mevrometostat in combination with enzalutamide is superior to either enzalutamide or docetaxel in prolonging radiographic progression-free survival in the mCRPC setting.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-30600248 elementor-widget elementor-widget-text-editor\" data-id=\"30600248\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tApproximately 600 participants will be randomly assigned in a 1:1 ratio to Arm A or Arm B.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5c925d11 detailsveritav2 e-flex e-con-boxed e-con e-parent\" data-id=\"5c925d11\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2c3b9a9a e-con-full e-flex e-con e-child\" data-id=\"2c3b9a9a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-80db81b elementor-widget elementor-widget-text-editor\" data-id=\"80db81b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n \t<li><span style=\"color: #097900; font-weight: 600;\">Investigational Arm A: <\/span><br>Mevrometostat 875 mg BID <span style=\"font-weight: 600;\">plus<\/span><br> enzalutamide 160 mg QD<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-25fdc07 e-con-full e-flex e-con e-child\" data-id=\"25fdc07\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d6e223f elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"d6e223f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><span style=\"color: #097900; font-weight: 600;\">Comparator Arm B: <\/span><br \/>Study doctor\u2019s choice of enzalutamide 160 mg QD <span style=\"font-weight: 600;\">OR<\/span><br \/>docetaxel 75 mg\/m<sup>2<\/sup> IV every cycle (21 days) for up to a maximum of 10 cycles.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-22d71a08 e-flex e-con-boxed e-con e-parent\" data-id=\"22d71a08\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2ad7d7cc elementor-widget elementor-widget-text-editor\" data-id=\"2ad7d7cc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tParticipants will receive investigational treatment until radiographic disease progression, unacceptable toxicity, protocol violation, withdrawal or study termination. The length of participation in MEVPRO-1 will vary depending on how well participants tolerate the study treatment or time to disease progression. \n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4e7b51a elementor-widget elementor-widget-text-editor\" data-id=\"4e7b51a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tThe study includes a 28-day screening period, the treatment period and a 28- to 35-day safety follow-up. The treatment period in the study will consist of cycles of 3 weeks (docetaxel group) or 4 weeks (enzalutamide groups). Participants receiving investigational mevrometostat and enzalutamide or enzalutamide alone will attend 2 study visits in Cycles 1 and 2, then 1 study visit per cycle thereafter. Participants receiving standard-of-care docetaxel will attend 1 study visit per cycle for up to 10 cycles. \n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-024c71f elementor-widget elementor-widget-text-editor\" data-id=\"024c71f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tLong-term safety follow-up will consist of visits every 12 weeks from the last dose until the study is complete, which may take many years, or until the participant withdraws consent.\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4445dbb5 e-con-full e-flex e-con e-parent\" data-id=\"4445dbb5\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-610b58e0 elementor-widget elementor-widget-text-editor\" data-id=\"610b58e0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tParticipant eligibility \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5f8244e5 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"5f8244e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"37\" height=\"38\" viewbox=\"0 0 37 38\" fill=\"none\"><path d=\"M35.8058 19.1635C35.8058 28.7761 28.0143 36.5685 18.4029 36.5685C8.79155 36.5685 1 28.7761 1 19.1635C1 9.55103 8.79155 1.75854 18.4029 1.75854\" stroke=\"#00009D\" stroke-width=\"2\"><\/path><path d=\"M34.4319 4.04865L18.4029 23.5148L11.0753 17.5604\" stroke=\"#097900\" stroke-width=\"2\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Key inclusion criteria:<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3419d371 elementor-widget elementor-widget-text-editor\" data-id=\"3419d371\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n \t<li>Male participants \u226518 years of age at screening.\n<\/li>\n \t<li>Histologically- or cytologically-confirmed adenocarcinoma of the prostate without small cell features. \n<\/li>\n\n \t<li>Metastatic disease in bone documented on bone scan, or in soft tissue documented on CT\/MRI scan. \n<\/li>\n \t<li>Evidence of disease progression on or after treatment with at least 12 weeks of abiraterone acetate in the metastatic castrate-sensitive prostate (mCSPC) cancer or first-line mCRPC setting.\n<\/li>\n\n\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3253b30c elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"3253b30c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"38\" height=\"39\" viewbox=\"0 0 38 39\" fill=\"none\"><path d=\"M36.7946 19.2892C36.7946 29.4096 28.7624 37.5785 18.8973 37.5785C9.03215 37.5785 1 29.4096 1 19.2892C1 9.16892 9.03215 1 18.8973 1C28.7624 1 36.7946 9.16892 36.7946 19.2892Z\" stroke=\"#00009D\" stroke-width=\"2\"><\/path><path d=\"M9.94592 9.64453L28.3459 28.9338\" stroke=\"#097900\" stroke-width=\"2\"><\/path><path d=\"M28.5946 9.89832L9.69731 28.6799\" stroke=\"#097900\" stroke-width=\"2\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Key exclusion criteria:<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39687a30 elementor-widget elementor-widget-text-editor\" data-id=\"39687a30\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n \t<li>Treatment with chemotherapy since becoming castrate-resistant.\n<\/li>\n \t<li>History of any other cancer in the last 3 years (except for some skin cancers or early-stage cancers that have been cured).\n<\/li>\n \t<li>Clinically significant cardiovascular disease, renal disease or liver disease.\n<\/li>\n \t<li>Prior treatment for prostate cancer at any stage with any cytotoxic chemotherapy, radioligand therapy, ARSi (including enzalutamide, apalutamide, darolutamide), PARP monotherapy or other systemic anti-cancer treatment.\n<\/li>\n \t<li>Major surgery or palliative localised radiation therapy within 14 days before randomisation.\n<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-713f9797 e-flex e-con-boxed e-con e-parent\" data-id=\"713f9797\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2f78d127 elementor-widget elementor-widget-text-editor\" data-id=\"2f78d127\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style>.elementor-element-2f78d127{display:none !important}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-22c06a92 elementor-widget elementor-widget-text-editor\" data-id=\"22c06a92\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<span style=\"font-weight: 600;\">Thank you for considering this clinical trial.<\/span>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4990c650 elementor-align-right IDs-btn elementor-widget elementor-widget-button\" data-id=\"4990c650\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"closebtn\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#MEVPRO-1\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"42\" height=\"42\" viewbox=\"0 0 42 42\" fill=\"none\"><circle cx=\"21\" cy=\"21\" r=\"21\" fill=\"#097900\"><\/circle><path d=\"M13 24L21 16L29 24\" stroke=\"white\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3c3ac92f elementor-widget elementor-widget-html\" data-id=\"3c3ac92f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<script>\n    document.addEventListener(\"DOMContentLoaded\", function() {\n      document.getElementById(\"closebtn\").onclick = function() {\n        var moreInfoSection = document.getElementById(\"moreinfo\");\n        moreInfoSection.style.display = (moreInfoSection.style.display === \"none\" || moreInfoSection.style.display === \"\") ? \"block\" : \"none\";\n  \n        \/\/ Toggle visibility of morebtn and morebtnopen\n        document.getElementById(\"morebtn\").style.display = \"block\";\n        document.getElementById(\"morebtnopen\").style.display = \"none\";\n      };\n  \n      document.getElementById(\"morebtnopen\").onclick = function() {\n        var moreInfoSection = document.getElementById(\"moreinfo\");\n        moreInfoSection.style.display = (moreInfoSection.style.display === \"none\" || moreInfoSection.style.display === \"\") ? \"block\" : \"none\";\n  \n        \/\/ Toggle visibility of morebtn and morebtnopen\n        document.getElementById(\"morebtn\").style.display = \"block\";\n        document.getElementById(\"morebtnopen\").style.display = \"none\";\n      };\n    });\n  <\/script>\n  \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-00be4aa e-flex e-con-boxed e-con e-parent\" data-id=\"00be4aa\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-21c39cd elementor-widget elementor-widget-heading\" data-id=\"21c39cd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Thank you for considering Pfizer\u2019s MEVPRO Prostate Cancer Clinical Trials.  <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b188a5f e-flex e-con-boxed e-con e-parent\" data-id=\"b188a5f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-11a6f1c e-con-full e-flex e-con e-child\" data-id=\"11a6f1c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d60c0ec elementor-widget elementor-widget-text-editor\" data-id=\"d60c0ec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>How clinical trials work<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6bfe395 elementor-widget elementor-widget-image\" data-id=\"6bfe395\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\/en-au\/clinical-trials\/\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"49\" height=\"49\" src=\"https:\/\/mevproclinicaltrials.com\/wp-content\/uploads\/2024\/09\/preFooter.svg\" class=\"attachment-large size-large wp-image-172\" alt=\"\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-572cd84 e-con-full e-flex e-con e-child\" data-id=\"572cd84\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-53bbb16 elementor-widget elementor-widget-text-editor\" data-id=\"53bbb16\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tSteps to join a clinical trial\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a2e0214 elementor-widget elementor-widget-image\" data-id=\"a2e0214\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\/en-au\/steps-to-join\/\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"49\" height=\"49\" src=\"https:\/\/mevproclinicaltrials.com\/wp-content\/uploads\/2024\/09\/preFooter.svg\" class=\"attachment-large size-large wp-image-172\" alt=\"\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-87bed07 e-con-full e-flex e-con e-child\" data-id=\"87bed07\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-94f0d2f elementor-widget elementor-widget-text-editor\" data-id=\"94f0d2f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tProtecting your safety and privacy\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2b7ca47 elementor-widget elementor-widget-image\" data-id=\"2b7ca47\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\/en-au\/privacy\/\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"49\" height=\"49\" src=\"https:\/\/mevproclinicaltrials.com\/wp-content\/uploads\/2024\/09\/preFooter.svg\" class=\"attachment-large size-large wp-image-172\" alt=\"\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b20ecc1 e-con-full e-flex e-con e-child\" data-id=\"b20ecc1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e92688e elementor-widget-tablet__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"e92688e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tFAQ\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-61b0a47 elementor-widget elementor-widget-image\" data-id=\"61b0a47\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\/en-au\/faq\/\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"49\" height=\"49\" src=\"https:\/\/mevproclinicaltrials.com\/wp-content\/uploads\/2024\/09\/preFooter.svg\" class=\"attachment-large size-large wp-image-172\" alt=\"\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Pfizer MEVPRO Prostate Cancer Clinical Trials Help advance metastatic prostate cancer treatment research Explore Pfizer\u2019s MEVPRO Clinical Trials as potential options for your patients Not yet recruiting Recruiting MEVPRO-1For your patients with abiraterone-resistant metastatic prostate cancer Clinicaltrials.gov Clinicaltrialsregister.eu A Phase 3 clinical trial evaluating the investigational medicine (mevrometostat) in combination with enzalutamide compared to enzalutamide [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"single_temp_hcp_trial.php","meta":{"footnotes":""},"class_list":["post-360","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/pages\/360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/comments?post=360"}],"version-history":[{"count":0,"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/pages\/360\/revisions"}],"wp:attachment":[{"href":"https:\/\/mevproclinicaltrials.com\/en-au\/wp-json\/wp\/v2\/media?parent=360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}